ADVERTISEMENT
Ajai Chari, MD, Talks Talquetamab for Relapsed/Refractory MM
12/05/2020
In this video, Dr Chari discusses the findings of a phase 1 trial examining the use of talquetamab in heavily pretreated patients with relapsed or refractory multiple myeloma (MM).
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Visit the OLN Excellence Forums
Advertisement
Advertisement
Advertisement